GI Innovation wins substance patent of immunotherapy GI-101 in US < Bio < 기사본문 - KBR
Patents, Intellectual Property News
The patent is not limited to the “amino acid sequence,” which makes it difficult for other rivals to evade the patent. In addition, the broad scope of ...
